Medication info
Jaymaril Tablet 2 mg (Glymepiride)

Jaymaril Tablet 2 mg (Glymepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Green elongated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200400194 · Notified 2004.10.01 · Insurance code 645403490

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, little additional benefit is seen with doses above 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg per day fails, first consider switching to insulin therapy; otherwise, consider use in combination with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial Dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the medicine previously used. 4) Dose adjustment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycosylated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur after treatment with a sulfonylurea, even if it was initially managed successfully. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate treatment and follow-up by a physician and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately once a week according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is coadministered with metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes, in conjunction with diet and exercise therapy. It can also be effective when used alone. If blood sugar control is insufficient with oral hypoglycemic agents, it may be used in combination with insulin. Additionally, if control with sulfonylureas or metformin alone is inadequate, it is administered in combination with metformin. This helps to effectively control blood sugar through various methods.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, little additional benefit is seen with doses above 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg per day fails, first consider switching to insulin therapy; otherwise, consider use in combination with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial Dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the medicine previously used. 4) Dose adjustment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycosylated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur after treatment with a sulfonylurea, even if it was initially managed successfully. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate treatment and follow-up by a physician and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately once a week according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is coadministered with metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a comatose state. Patients who are allergic to this medication or sulfonylureas, those with severe liver or kidney dysfunction, pregnant or nursing women, patients with severe infections or those undergoing surgery, and individuals with gastrointestinal disorders such as diarrhea or vomiting should also avoid taking it. There is a high risk of hypoglycemia in the early stages of treatment; therefore, elderly patients, those with poor nutritional status or who skip meals, frequent alcohol consumers, individuals with reduced kidney or liver function, and those with endocrine disorders should be particularly cautious. Patients should be aware of hypoglycemia symptoms and treatment, and it is important to consume sugar immediately if hypoglycemia occurs. This medication can interact with various drugs, so patients taking other medications should inform their doctor or pharmacist. Pregnant or nursing women are advised not to use this medication; switching to insulin therapy is recommended if necessary. Its safety and efficacy have not been established in individuals under 18 years of age, so its use is not recommended. Elderly patients may have decreased kidney function, so care should be taken to adjust the dosage accordingly. In the event of an overdose, severe hypoglycemia may occur; immediate medical assistance should be sought, and glucose should be administered promptly upon the appearance of hypoglycemic symptoms. This medication should be stored out of the reach of children and kept sealed in its original container.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, language abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, hives, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, indigestion, facial edema, erectile dysfunction, flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is recommended to store it at room temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain its effectiveness for a longer duration.

Appearance and packaging

Appearance

Green elongated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.